Published in Int J Med Microbiol on September 23, 2009
A new zebrafish model of oro-intestinal pathogen colonization reveals a key role for adhesion in protection by probiotic bacteria. PLoS Pathog (2012) 1.00
Probiotics for the control of parasites: an overview. J Parasitol Res (2011) 0.99
Evaluation of methods to purify virus-like particles for metagenomic sequencing of intestinal viromes. BMC Genomics (2015) 0.90
Microencapsulation of Saccharomyces cerevisiae and its evaluation to protect in simulated gastric conditions. Iran J Microbiol (2015) 0.79
New Insights on the Use of Dietary Polyphenols or Probiotics for the Management of Arterial Hypertension. Front Physiol (2016) 0.75
Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites. J Clin Med (2016) 0.75
Lactic acid bacteria-specific induction of CD4(+)Foxp3(+)T cells ameliorates shrimp tropomyosin-induced allergic response in mice via suppression of mTOR signaling. Sci Rep (2017) 0.75
Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens. Gut Pathog (2017) 0.75
Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol (2006) 3.82
Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis (2014) 2.59
Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation (2006) 2.41
Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr (2010) 2.17
Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res (2003) 2.07
Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS One (2007) 2.05
Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77
Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One (2013) 1.30
Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br J Nutr (2003) 1.26
Reclassification of Eubacterium formicigenerans Holdeman and Moore 1974 as Dorea formicigenerans gen. nov., comb. nov., and description of Dorea longicatena sp. nov., isolated from human faeces. Int J Syst Evol Microbiol (2002) 1.22
Anaerostipes caccae gen. nov., sp. nov., a new saccharolytic, acetate-utilising, butyrate-producing bacterium from human faeces. Syst Appl Microbiol (2002) 1.17
Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr Res (2008) 1.14
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol (2006) 1.13
Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology (2005) 1.11
Isolation of bacteria from the ileal mucosa of TNFdeltaARE mice and description of Enterorhabdus mucosicola gen. nov., sp. nov. Int J Syst Evol Microbiol (2009) 1.11
Clostridium saccharogumia sp. nov. and Lactonifactor longoviformis gen. nov., sp. nov., two novel human faecal bacteria involved in the conversion of the dietary phytoestrogen secoisolariciresinol diglucoside. Syst Appl Microbiol (2007) 1.10
Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr (2011) 1.09
Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes (2012) 1.08
Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol (2005) 1.06
Modulation of gut mucosal biofilms. Br J Nutr (2005) 1.03
Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol (2008) 1.02
The Toll-like receptors TLR2 and TLR4 do not affect the intestinal microbiota composition in mice. Environ Microbiol (2007) 1.01
Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes (2011) 1.00
Intestinimonas butyriciproducens gen. nov., sp. nov., a butyrate-producing bacterium from the mouse intestine. Int J Syst Evol Microbiol (2013) 1.00
Occurrence and activity of human intestinal bacteria involved in the conversion of dietary lignans. Anaerobe (2005) 0.99
Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One (2009) 0.99
Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ Microbiol (2009) 0.97
Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. J Proteome Res (2009) 0.97
Quantification of human fecal bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Appl Environ Microbiol (2012) 0.96
Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett (2002) 0.96
Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis (2011) 0.94
Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol (2003) 0.94
Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. J Nutr (2005) 0.94
Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl Environ Microbiol (2009) 0.93
Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl Environ Microbiol (2008) 0.92
Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl Environ Microbiol (2010) 0.92
Phylogeny of human intestinal bacteria that activate the dietary lignan secoisolariciresinol diglucoside. FEMS Microbiol Ecol (2006) 0.90
Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ Microbiol (2008) 0.90
Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos (2009) 0.89
The gastrointestinal microbiota affects the selenium status and selenoprotein expression in mice. J Nutr Biochem (2008) 0.89
The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats. J Nutr (2009) 0.88
Identification and expression of genes involved in the conversion of daidzein and genistein by the equol-forming bacterium Slackia isoflavoniconvertens. Appl Environ Microbiol (2013) 0.88
Cloning and expression of a phloretin hydrolase gene from Eubacterium ramulus and characterization of the recombinant enzyme. Appl Environ Microbiol (2004) 0.88
Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J Nutr (2011) 0.88
Bioavailability of lignans in human subjects. Nutr Res Rev (2006) 0.86
Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria. PLoS One (2013) 0.86
Intestinal steroid profiles and microbiota composition in colitic mice. Gut Microbes (2011) 0.85
The thermal and enzymatic taxifolin-alphitonin rearrangement. J Nat Prod (2011) 0.85
Changes in dominant groups of the gut microbiota do not explain cereal-fiber induced improvement of whole-body insulin sensitivity. Nutr Metab (Lond) (2011) 0.84
Deglycosylation of puerarin and other aromatic C-glucosides by a newly isolated human intestinal bacterium. Environ Microbiol (2010) 0.83
The peptide transporter PEPT1 is expressed in distal colon in rodents and humans and contributes to water absorption. Am J Physiol Gastrointest Liver Physiol (2013) 0.83
Recovery and metabolism of xanthohumol in germ-free and human microbiota-associated rats. Mol Nutr Food Res (2010) 0.82
Bacterial transformation of dietary lignans in gnotobiotic rats. FEMS Microbiol Ecol (2010) 0.81
Xanthohumol does not affect the composition of rat intestinal microbiota. Mol Nutr Food Res (2005) 0.80
Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications. J Clin Gastroenterol (2010) 0.80
Occurrence of the human tumor-specific antigen structure Galβ1-3GalNAcα- (Thomsen-Friedenreich) and related structures on gut bacteria: prevalence, immunochemical analysis and structural confirmation. Glycobiology (2011) 0.80
Purification and characterization of an NADH oxidase from Eubacterium ramulus. Arch Microbiol (2002) 0.80
Marker rescue studies of the transfer of recombinant DNA to Streptococcus gordonii in vitro, in foods and gnotobiotic rats. Appl Environ Microbiol (2003) 0.80
Conversion of dehydrodiferulic acids by human intestinal microbiota. J Agric Food Chem (2009) 0.80
Mild gut inflammation modulates the proteome of intestinal Escherichia coli. Environ Microbiol (2013) 0.79
Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst Appl Microbiol (2005) 0.79
Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl Environ Microbiol (2011) 0.79
The growth of the flavonoid-degrading intestinal bacterium, Eubacterium ramulus, is stimulated by dietary flavonoids in vivo. FEMS Microbiol Ecol (2002) 0.79
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol Immunother (2013) 0.78
Acetatifactor muris gen. nov., sp. nov., a novel bacterium isolated from the intestine of an obese mouse. Arch Microbiol (2012) 0.78
Coffee dietary fiber contents and structural characteristics as influenced by coffee type and technological and brewing procedures. J Agric Food Chem (2007) 0.78
First bacterial chalcone isomerase isolated from Eubacterium ramulus. Arch Microbiol (2004) 0.78
Impact of nutritional factors on the proteome of intestinal Escherichia coli: induction of OxyR-dependent proteins AhpF and Dps by a lactose-rich diet. Appl Environ Microbiol (2012) 0.78
Degradation of neohesperidin dihydrochalcone by human intestinal bacteria. J Agric Food Chem (2005) 0.78
Novel insights into E. coli's hexuronate metabolism: KduI facilitates the conversion of galacturonate and glucuronate under osmotic stress conditions. PLoS One (2013) 0.77
Increased bacterial permeation in long-lasting ileoanal pouches. Inflamm Bowel Dis (2006) 0.77
Gut health: predictive biomarkers for preventive medicine and development of functional foods. Br J Nutr (2010) 0.77
Intestinal bacterium Eubacterium cellulosolvens deglycosylates flavonoid C- and O-glucosides. Appl Environ Microbiol (2012) 0.77
Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats. Br J Nutr (2012) 0.76
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS PharmSciTech (2004) 0.76
A derivatization method for the simultaneous detection of glucosinolates and isothiocyanates in biological samples. Anal Biochem (2013) 0.76
Characterization of high molecular weight coffee fractions and their fermentation by human intestinal microbiota. Mol Nutr Food Res (2009) 0.76
Bioavailability and biotransformation of sulforaphane and erucin metabolites in different biological matrices determined by LC-MS-MS. Anal Bioanal Chem (2015) 0.76